These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 27784733)
61. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ; ; ; Circulation; 2004 Jul; 110(2):227-39. PubMed ID: 15249516 [TBL] [Abstract][Full Text] [Related]
62. Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trial. Rosenson RS; Otvos JD; Freedman DS Am J Cardiol; 2002 Jul; 90(2):89-94. PubMed ID: 12106834 [TBL] [Abstract][Full Text] [Related]
63. Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy. Otvos JD Clin Lab; 2002; 48(3-4):171-80. PubMed ID: 11934219 [No Abstract] [Full Text] [Related]
64. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. Knowler WC; Barrett-Connor E; Fowler SE; Hamman RF; Lachin JM; Walker EA; Nathan DM; N Engl J Med; 2002 Feb; 346(6):393-403. PubMed ID: 11832527 [TBL] [Abstract][Full Text] [Related]
65. Variability in the response of HDL cholesterol to exercise training in the HERITAGE Family Study. Leon AS; Gaskill SE; Rice T; Bergeron J; Gagnon J; Rao DC; Skinner JS; Wilmore JH; Bouchard C Int J Sports Med; 2002 Jan; 23(1):1-9. PubMed ID: 11774059 [TBL] [Abstract][Full Text] [Related]
66. The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes. The Diabetes Prevention Program Research Group Diabetes Care; 1999 Apr; 22(4):623-34. PubMed ID: 10189543 [TBL] [Abstract][Full Text] [Related]
67. Individual variation in plasma cholesterol response to dietary saturated fat. Cox C; Mann J; Sutherland W; Ball M BMJ; 1995 Nov; 311(7015):1260-4. PubMed ID: 7496234 [TBL] [Abstract][Full Text] [Related]
69. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Friedewald WT; Levy RI; Fredrickson DS Clin Chem; 1972 Jun; 18(6):499-502. PubMed ID: 4337382 [No Abstract] [Full Text] [Related]
70. Enzymatic methods for quantification of lipoprotein lipids. Warnick GR Methods Enzymol; 1986; 129():101-23. PubMed ID: 3724535 [No Abstract] [Full Text] [Related]
72. Targeting the consequences of the metabolic syndrome in the Diabetes Prevention Program. Goldberg RB; Mather K Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2077-90. PubMed ID: 22895669 [TBL] [Abstract][Full Text] [Related]
73. Effect of Fructose on Established Lipid Targets: A Systematic Review and Meta-Analysis of Controlled Feeding Trials. Chiavaroli L; de Souza RJ; Ha V; Cozma AI; Mirrahimi A; Wang DD; Yu M; Carleton AJ; Di Buono M; Jenkins AL; Leiter LA; Wolever TM; Beyene J; Kendall CW; Jenkins DJ; Sievenpiper JL J Am Heart Assoc; 2015 Sep; 4(9):e001700. PubMed ID: 26358358 [TBL] [Abstract][Full Text] [Related]